0001181431-12-066889.txt : 20121221
0001181431-12-066889.hdr.sgml : 20121221
20121221182447
ACCESSION NUMBER: 0001181431-12-066889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121219
FILED AS OF DATE: 20121221
DATE AS OF CHANGE: 20121221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caballa Susan
CENTRAL INDEX KEY: 0001489530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 121283159
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: SUITE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 6789905740
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY
STREET 2: STE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
rrd364460.xml
FORM 4
X0306
4
2012-12-19
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001489530
Caballa Susan
6120 WINDWARD PARKWAY, SUITE 290
ALPHARETTA
GA
30005
0
1
0
0
SVP,Regulatory&Medical Affairs
Employee Stock Option (Right to Buy)
1.66
2012-12-19
4
A
0
90000
0
A
2022-12-18
Common Stock
90000
90000
D
Employee Stock Option (Right to Buy)
1.66
2012-12-19
4
A
0
35000
0
A
2022-12-18
Common Stock
35000
35000
D
This option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period.
This option shall become exercisable if and only if on or before June 30, 2013 the United Kingdom's National Institute for Health and Clinical Excellence recommends ILUVIEN(R) for the treatment of diabetic macular edema, in which case this option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period.
/s/ Susan Caballa
2012-12-20